“…the proportion of people without disease who have a negative result) of >90% (Saad et al, 2002;Simon, et al, 2003), it has some important limitations: it has inadequate sensitivity, particularly in well or moderately differentiated tumours (McDonald et al, 2006). Studies have shown that this expensive test (Araki et al, 2007) provides little unique information leading to the diagnosis of bladder cancer (Hofland and Mariani, 2004) and at best its role is supportive. Studies have shown that this expensive test (Araki et al, 2007) provides little unique information leading to the diagnosis of bladder cancer (Hofland and Mariani, 2004) and at best its role is supportive.…”